Atherothrombosis and high-risk plaque: part I: evolving concepts.
By Valentin Fuster, P. Moreno, Z. Fayad, R. Corti, J. Badimón. Journal of the American College of Cardiology, 2005
833 citations recorded by the source corpus.
Subfields: Immunology, Immunology and Allergy, Surgery
View Paper: https://www.semanticscholar.org/paper/f7cae4812748b6bf654b0b6a139d83952a8b1384
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- F. Crea
- Volkmar Falk
- Gerasimos Filippatos
- Jeroen J. Bax
- F. Werf
- A. Betriu
- M. Tendera
- C. Blomström-Lundqvist
Citations in the corpus
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. (2008, background): “The risk of plaque disruption depends on plaque composition and vulnerability (plaque type) and degree of stenosis (plaque size).(3) As many as three-quarters of all infarct-related thrombi appear to evolve over plaques causing only mild to moderate stenosis.”
- Myocardial no-reflow in humans. (2009, background): “consequences of coronary ligation of a nonatherosclerotic coronary artery, however, cannot be directly extrapolated to the human situation where myocardial infarction is caused by occlusive coronary thrombosis superimposed onto an atherosclerotic unstable plaque (13).”